Obrien Eye Care | |
426 E Main St, Charleston, MS 38921-2413 | |
(662) 647-8707 | |
(662) 647-8706 |
Full Name | Obrien Eye Care |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 426 E Main St, Charleston, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528249497 | NPI | - | NPPES |
00087700 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 426 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Obrien Eye Care Po Box 354, Charleston, MS 38921-0354 Ph: (662) 647-8707 | Obrien Eye Care 426 E Main St, Charleston, MS 38921-2413 Ph: (662) 647-8707 |
News Archive
The results of a new survey published in ecancermedicalscience indicate that a majority of oncology professionals believe that writing condolence letters to the families of deceased patients is an important component of cancer palliative care.
ImmunoCellular Therapeutics, Ltd., announced that Surasak Phuphanich, MD, Principal Investigator of the Phase I clinical trial of ImmunoCellular's lead dendritic cell cancer vaccine candidate for glioblastoma multiforme presented safety and preliminary efficacy data yesterday at the American Academy of Neurology 63rd Annual Meeting.
Scientists at Stanford and UC-San Francisco have developed an experimental drug that targets a currently untreatable type of lung cancer responsible for generating roughly 500,000 newly diagnosed cases worldwide each year.
A new material developed at the University of Virginia - an oxygen nanosensor that couples a light-emitting dye with a biopolymer - simplifies the imaging of oxygen-deficient regions of tumors. Such tumors are associated with increased cancer aggressiveness and are particularly difficult to treat.
Warner Chilcott plc (Nasdaq: WCRX) and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion to Warner Chilcott, LEO Pharma is re-acquiring Warner Chilcott's exclusive product licensing rights in the United States to its topical psoriasis treatments Taclonex(R), Taclonex Scalp(R), Dovonex(R) as well as rights to all products in LEO's development pipeline, and acquiring all inventories of the products.
› Verified 3 days ago
Tallahatchie Eyecare, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 203 S Market St, Charleston, MS 38921 Phone: 662-647-3500 | |
David V Obrien, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 426 E Main St, Charleston, MS 38921 Phone: 662-647-8707 Fax: 662-647-8706 | |
Charleston Vision Center Pa Optometrist Medicare: Medicare Enrolled Practice Location: 288 W Main St, Charleston, MS 38921 Phone: 662-647-8707 Fax: 662-647-8706 |